This Is What Whales Are Betting On Regeneron Pharmaceuticals
Portfolio Pulse from Benzinga Insights
A large investor has taken a bullish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 10 uncommon options trades spotted, split between 50% bullish and 50% bearish. Whales have been targeting a price range of $720 to $870 for REGN over the last 3 months.
May 19, 2023 | 2:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
A large investor has taken a bullish stance on Regeneron Pharmaceuticals, with 10 uncommon options trades spotted. Whales have been targeting a price range of $720 to $870 for REGN over the last 3 months.
The article highlights a large investor taking a bullish stance on Regeneron Pharmaceuticals, with 10 uncommon options trades spotted. This indicates that the investor believes the stock price will increase in the short term. Additionally, the targeted price range of $720 to $870 by whales over the last 3 months suggests that there is potential for the stock price to rise within this range. The analyst ratings also provide a mixed outlook, with some maintaining a Buy rating and others downgrading their actions.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100